C. Lefaucheur, A. Loupy, G. S. Hill, J. Andrade, D. Nochy et al., Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J. Am. Soc. Nephrol, vol.21, pp.1398-1406, 2010.
DOI : 10.1681/asn.2009101065
URL : https://jasn.asnjournals.org/content/21/8/1398.full.pdf

M. Hourmant, Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation, J. Am. Soc. Nephrol, vol.16, pp.2804-2812, 2005.

S. Ferrari-lacraz, J. Tiercy, and J. Villard, Detection of anti-HLA antibodies by solid-phase assay in kidney transplantation: friend or foe?, Tissue Antigens, vol.79, pp.315-325, 2012.

Q. Mao, P. I. Terasaki, J. Cai, K. Briley, P. Catrou et al., Extremely high association between detection of HLA antibodies and failure of kidney grafts in a five-year longitudinal study, Am. J. Transpl, vol.7, pp.864-871, 2007.

P. I. Terasaki and M. Ozawa, Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial, Transplantation, vol.80, pp.1194-1197, 2005.

N. Lachmann, P. I. Terasaki, K. Budde, L. Liefeldt, A. Kahl et al., Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts, Transplantation, vol.87, pp.1505-1513, 2009.
DOI : 10.1097/tp.0b013e3181a44206

O. Thaunat, Humoral immunity in chronic allograft rejection: puzzle pieces come together, vol.26, pp.101-106, 2012.
DOI : 10.1016/j.trim.2011.11.003

C. Lefaucheur, C. Antoine, C. Suberbielle, and D. Glotz, Mastering the risk of HLA antibodies in kidney transplantation: an algorithm based on pretransplant single-antigen flow bead techniques, Am. J. Transpl, vol.11, pp.1592-1598, 2011.

A. Zeevi, J. G. Lunz, R. Shapiro, P. Randhawa, G. Mazariegos et al., Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation, Hum. Immunol, vol.70, pp.645-650, 2009.

H. S. Eng, G. Bennett, S. H. Chang, H. Dent, S. P. Mcdonald et al., Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy, Hum. Immunol, vol.72, pp.386-391, 2011.
DOI : 10.1016/j.humimm.2011.02.002

C. Lefaucheur, C. Suberbielle-boissel, G. S. Hill, D. Nochy, J. Andrade et al., Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation, Am. J. Transpl, vol.8, pp.324-331, 2008.

M. J. Everly, L. M. Rebellato, C. E. Haisch, K. P. Briley, P. Bolin et al., Impact of IgM and IgG3 anti-HLA alloantibodies in primary renal allograft recipients, Transplantation, vol.97, pp.494-501, 2014.

R. M. Anthony and J. V. Ravetch, A novel role for the IgG Fc glycan: the antiinflammatory activity of sialylated IgG Fcs, J. Clin. Immunol, vol.30, pp.9-14, 2010.

R. M. Anthony and F. Nimmerjahn, The role of differential IgG glycosylation in the interaction of antibodies with FcyRs in vivo, Curr. Opin. Organ Transpl, vol.16, pp.7-14, 2011.

Y. Kaneko, Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation, Science, vol.313, pp.670-673, 2006.
DOI : 10.1126/science.1129594

J. Stadlmann, A. Weber, M. Pabst, H. Anderle, R. J. Kunert et al., A close look at human IgG sialylation and subclass distribution after lectin fractionation, Proteomics, vol.9, pp.4143-4153, 2009.
DOI : 10.1002/pmic.200800931

F. Käsermann, D. J. Boerema, M. Rüegsegger, A. Hofmann, S. Wymann et al., Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation, PLoS ONE, vol.7, p.37243, 2012.

O. Gornik and G. Lauc, Enzyme linked lectin assay (ELLA) for direct analysis of transferrin sialylation in serum samples, Clin. Biochem, vol.40, pp.718-723, 2007.

C. Espy, W. Morelle, N. Kavian, P. Grange, C. Goulvestre et al., Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's), Arthritis Rheum, vol.63, pp.2105-2115, 2011.

D. Lowe, R. Higgins, D. Zehnder, and D. C. Briggs, Significant IgG subclass heterogeneity in HLA-specific antibodies: implications for pathogenicity, prognosis, and the rejection response, Hum. Immunol, vol.74, pp.666-672, 2013.
DOI : 10.1016/j.humimm.2013.01.008

Y. Ogasawara, T. Namai, F. Yoshino, M. Lee, and K. Ishii, Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger, FEBS Lett, vol.581, pp.2473-2477, 2007.

A. Loupy, C. Lefaucheur, D. Vernerey, C. Prugger, J. D. Van-huyen et al., Complement-binding anti-HLA antibodies and kidney-allograft survival, N. Engl. J. Med, vol.369, pp.1215-1226, 2013.

F. Nimmerjahn and J. V. Ravetch, Fcc receptors as regulators of immune responses, Nat. Rev. Immunol, vol.8, pp.34-47, 2008.

M. Pucic, A. Knezevic, J. Vidic, B. Adamczyk, M. Novokmet et al., High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations, Mol. Cell. Proteomics, vol.10, 2011.

R. Kannagi, M. Izawa, T. Koike, K. Miyazaki, and N. Kimura, Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis, Cancer Sci, vol.95, pp.377-384, 2004.

B. J. Scallon, S. H. Tam, S. G. Mccarthy, A. N. Cai, and T. S. Raju, Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality, Mol. Immunol, vol.44, pp.1524-1534, 2007.

W. F. Broekaert, M. Nsimba-lubaki, B. Peeters, and W. J. Peumans, A lectin from elder (Sambucus nigra L.) bark, Biochem. J, vol.221, p.163, 1984.

R. M. Anthony, F. Wermeling, and J. V. Ravetch, Novel roles for the IgG Fc glycan, Ann. N.Y. Acad. Sci, vol.1253, pp.170-180, 2012.

M. B. Jones, M. Nasirikenari, A. A. Lugade, Y. Thanavala, and J. T. Lau, Antiinflammatory IgG production requires functional P1 promoter ingalactoside 2,6-sialyltransferase 1 (ST6Gal-1) gene, J. Biol. Chem, vol.287, pp.15365-15370, 2012.

H. S. Pollinger, M. D. Stegall, J. M. Gloor, S. B. Moore, S. R. Degoey et al., Kidney transplantation in patients with antibodies against donor HLA class II, Am. J. Transpl, vol.7, pp.857-863, 2007.

C. Taflin, D. Charron, D. Glotz, and N. Mooney, Immunological function of the endothelial cell within the setting of organ transplantation, Immunol. Lett, vol.139, pp.1-6, 2011.

B. Sis, P. M. Campbell, T. Mueller, C. Hunter, S. M. Cockfield et al., Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause, Am. J. Transpl, vol.7, pp.1743-1752, 2007.

F. M. Naemi, V. Carter, J. A. Kirby, and S. Ali, Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection, Transpl. J, vol.96, pp.258-266, 2013.

E. F. Reed, Mechanisms of action and effects of antibodies on the cells of the allograft, Hum. Immunol, vol.73, pp.1211-1212, 2012.

R. M. Anthony, F. Wermeling, M. C. Karlsson, and J. V. Ravetch, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc. Natl. Acad. Sci, vol.105, pp.19571-19578, 2008.

A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racapé et al., Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype, Kidney Int, vol.78, pp.503-513, 2010.

A. Baerenwaldt, A. Lux, H. Danzer, B. M. Spriewald, E. Ullrich et al., Fc receptor IIB (Fc RIIB) maintains humoral tolerance in the human immune system in vivo, Proc. Natl. Acad. Sci, vol.108, pp.18772-18777, 2011.

M. R. Clatworthy, B-cell regulation and its application to transplantation, Transpl. Int, vol.27, pp.117-128, 2014.